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In a gene trap screen we recovered a mouse mutant line in which an insertion generated a null allele of the
Brd4 gene. Brd4 belongs to the Fsh/Brd family, a group of structurally related proteins characterized by the
association of two bromodomains and one extraterminal domain. Members of this family include Brd2/Ring3/
Fsrg1 in mammals, fs(1)h in Drosophila, and Bdf1 in Saccharomyces cerevisiae. Brd4 heterozygotes display pre-
and postnatal growth defects associated with a reduced proliferation rate. These mice also exhibit a variety of
anatomical abnormalities: head malformations, absence of subcutaneous fat, cataracts, and abnormal liver
cells. In primary cell cultures, heterozygous cells also display reduced proliferation rates and moderate
sensitivity to methyl methanesulfonate. Embryos nullizygous for Brd4 die shortly after implantation and are
compromised in their ability to maintain an inner cell mass in vitro, suggesting a role in fundamental cellular
processes. Finally, sequence comparisons suggest that Brd4 is likely to correspond to the Brd-like element of
the mediator of transcriptional regulation isolated by Y. W. Jiang, P. Veschambre, H. Erdjument-Bromage, P.
Tempst, J. W. Conaway, R. C. Conaway, and R. D. Kornberg (Proc. Natl. Acad. Sci. USA 95:8538-8543, 1998)
and the Brd4 mutant phenotype is discussed in light of this result. Together, our results provide the first genetic
evidence for an in vivo role in mammals for a member of the Fsh/Brd family.
The bromodomain is a conserved 110-amino acid motif
which specifically interacts with acetyl-lysines, at least in the
context of short histone H3 and H4 peptides (reference 9; see
also reference 39). Although bromodomains have now been
found in more than 40 different proteins (13, 17, 39), the
function of this motif is poorly understood. The association of
two N-terminal bromodomains with a C-terminal extratermi-
nal (ET) domain defines the Fsh/Brd subgroup (23), which
includes members in many species: Saccharomyces cerevisiae
(Bdf1 and Bdf2) (5, 23, 24), Caenorhabditis elegans (cefsh)
(36), Drosophila [fs(1)h, previously called fsh (Flybase nomen-
clature)] (14), and hagfish (hffsh; GenBank accession no.
AF191032). In vertebrates, four members of the Fsh/Brd sub-
group have now been identified: Brd2/RING3/fsrg1 (1, 32, 36),
Brd3/ORFX/fsrg2 (37), Brd4/HUNK1/MCAP (8), and Brd5/
BRDT (19).
The yeast Bdf1 protein interacts with the general transcrip-
tion factor TFIID (24) as well as with histones H3 and H4 (28),
and the Bdf1 mutant phenotype shares features with those of
mutants affected in general transcription (23). Bdf1 mutants
display a reduced rate of vegetative growth, failure to undergo
one or both meiotic divisions, and sensitivity to the DNA-
damaging agent methyl methanesulfonate (MMS). Some al-
leles of Drosophila fs(1)h cause partial or complete loss of
segments and homeotic transformations in progeny of mutant
females (10, 14), but little is known about the molecular prop-
erties of its product. In vertebrates, the human Brd2 protein
has been identified as a mitogen-activated nuclear protein as-
sociated with a kinase activity (6, 30, 32) and a regulator of
E2F-dependent cell cycle genes (7).
In a gene trap screen designed to identify genes involved in
mouse development, we recovered an integration producing a
null allele of Brd4/MCAP, another member of the Brd/Fsh
family (8). We showed that the Brd4 nullizygous condition
results in early embryonic lethality. We also demonstrated that
only one functional allele of Brd4 is not able to sustain normal
development. Heterozygosity for Brd4 leads to pre- and post-
natal growth defects that are associated with reduced prolifer-
ation in vitro and in vivo. Together, our results provide the first
genetic evidence of an in vivo role for a Fsh/Brd family mem-
ber in mammals.
MATERIALS AND METHODS
Gene trap and rapid amplification of cDNA ends (RACE). Production of gene
trap embryonic stem (ES) cells and the gene trap vector (a kind gift of W.
Skarnes) was performed as described previously (4). The vector contained a
splice acceptor sequence upstream of the CD4 transmembrane domain se-
quence, a lacZ-neomycin-phosphotransferase fusion (-geo), and a polyadenyl-
ation signal such that integrations into introns of transcriptionally active genes
produce a -galactosidase fusion protein that contains an endogenous sequence
amino terminal to the site of insertion. The inclusion of a transmembrane
domain-encoding region in the vector was designed to enrich for insertions
downstream of secretory signal sequences of type I transmembrane domains,
because -galactosidase activity is only preserved when the enzyme is retained in
the cytoplasm (34). Therefore, an unexpected aspect of our results while using
this vector was the isolation of a nuclear protein (34). In a systematic screen using
a similar vector, J. Brennan and W. Skarnes isolated genes coding for nonse-
creted proteins in 5 out of 12 cases, 3 of these involving insertion of the vector
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into the part of the gene corresponding to the 5 untranslated region (UTR), as
is the case for Brd4. In these cases, a functional -geo protein was presumably
produced via internal initiation of translation (reference 33 and J. Brennan,
personal communication).
RACE was performed as described previously (4). The ST132 RACE fragment
was used to screen an embryonic day 13 (E13) testis cDNA library (27) by
standard procedures. The cDNA sequence matched precisely the MCAP se-
quence described in the study cited in reference 8. The 3UTR of the 3.5-kb Brd4
clone was obtained by 3 RACE using a Marathon-Ready cDNA kit (Clontech)
and was cloned into a Topo II vector (Invitrogen). Reverse transcription-PCR
(RT-PCR) was performed using an Advantage One-Step RT-PCR Kit (Clon-
tech) (primer 1f, AAA TCA GCT CAC CAG GCTG T; primer 1r, TCT TGG
GCT TGT TAG GGT TG; primer 2r, CAC CAC CAG GTT CAC TTC CT).
Sequence comparison of the different members of the Brd family was performed
with ClustalX software (17, 35). Sequence alignment of the Ring3-like peptides
of the mediator with the different members of the Brd family was performed with
Lasergene software (DNASTAR).
Mouse strains. CGR8 ES cells (129/Ola) were used to generate the gene trap
cell lines (4, 34). Chimeras and their heterozygous progeny were backcrossed for
five to eight generations onto a C57BL6/J background. Heterozygous individuals
were obtained by mating a Brd4gt/Brd4 male with a C57BL6/J female in order
to avoid possible maternal effects of the Brd4gt allele. The day of detection of the
vaginal plug was defined as E0.
Radiation hybrid mapping. The mouse-hamster radiation hybrid (RH) panel
was used according to the supplier’s instructions (Research Genetics). Notch31f
(AGG GAC CTG TGT GGA TGG CGT GAG C) was used as an upstream
primer and Notch31r (CCA TTC TGA CAG GGT GCC TGG CTG C) was used
as a downstream primer to specifically amplify a 228-bp fragment from the
mouse Notch3 locus. 18f (CAA TCT GAC TGA GCT GTT CAT ATA GGT C)
was used as an upstream primer and 18r (GTT GTA GAC ATT TGG GAG GTT
TCT AGT C) was used as a downstream primer to specifically amplify a 414-bp
fragment from the mouse Brd4 locus. Maps and extensive information on mouse
RH can be found in The Jackson Laboratory RH database site (http://lena.jax
.org/resources/documents/cmdata/).
Histology, antibody staining, and in situ hybridization. The Brd4 common
probe contains the first 1,820 nucleotides of the published cDNA (NCBI acces-
sion number NM 0205508). X-Gal staining was performed as described previ-
ously (16). For in situ hybridization on blastocyst explants, blastocysts were
grown on gelatinized Lab-Tek chamber slide (catalog no. 177445; Nunc) in ES
cell culture medium without leukemia-inhibiting factor (LIF) (15) for 2 to 5 days.
The resulting culture was rinsed twice in phosphate-buffered saline, fixed for 4 h
in fresh 4% paraformaldehyde in phosphate-buffered saline, washed twice in
phosphate-buffered saline, and hybridized as previously described (25). The
anti-phospho-histone H3 antibody (catalog no. 06570; Upstate Biotechnology)
was used according to the specifications of the supplier (5 g/ml on paraffin
sections with antigen retrieval). For eosin-hematoxylin staining, organs were
fixed in Bouin’s fixative. After fixation, samples were processed, embedded in
paraffin, sectioned, and stained according to standard procedures. For skeleton
preparations, skulls from 2-month-old males were skinned, dehydrated in 95%
ethanol for 24 h, fat dissolved in acetone for 24 h, cleared in 2% KOH for about
3 h, and stained for 3 days in 0.015% alcian blue–0.005% alizarin red–5% acetic
acid in 60% ethanol. The skulls were then cleared in 2% KOH.
Mouse embryonic fibroblast culture and proliferation. Mouse embryonic fi-
broblasts were isolated and cultured as described in the study cited in reference
15 except that minced embryos were only trypsinized once at 37°C for 10 min and
spun down for 5 min and the pellet was plated. For the proliferation test, 1.00 
105 cells were harvested at day 0 and cells were counted at different time points
by using a hemocytometer. The MMS was supplied by Aldrich (catalog no.
12,992-5). UV irradiation was done in a Stratalinker apparatus using 254-nm
bulbs.
RESULTS
Isolation and characterization of the Brd4 gene. Isolation of
the Brd4 gene was performed as follows. ST132 was an ES cell
clone selected from a gene trap screen originally designed to
identify integrations into genes expressed during early murine
organogenesis (4, 34). After demonstration of the expression
of the lacZ reporter in midgestation chimeras, a mouse strain
carrying the ST132 integration was established (see Materials
and Methods).
5 RACE was used to clone a 209-bp fragment of the
trapped gene from the ST132 cell line. This fragment showed
no open reading frame or obvious homology to any sequence
from the databases. A probe corresponding to the ST132 5
RACE product was used to isolate a 1,890-bp clone from a
mouse embryonic testis cDNA library (27). The sequencing of
the complete cDNA was achieved by a combination of ex-
pressed sequence tag alignments, RT-PCR, and 3 RACE (Fig.
1a). The junction between the 5 RACE fragment and the
cDNA sequence, as well as the junction between the 5 RACE
fragment and the gene trap sequence, was confirmed by RT-
PCR (Fig. 1b). While this work was in progress, the same
cDNA was reported under the name MCAP (mitotic chromo-
some-associated protein (8). However, we have designated it
Brd4 for reasons of consistency with the nomenclature used for
the members of this family, as recommended by the Mouse
Gene Informatics Nomenclature Committee.
The Brd4 gene is transcribed from 20 exons. The Brd4 gene
encodes a putative 1,400-amino acid protein characterized by
the presence of two bromodomains in the N-terminal region of
the protein and an ET domain in the more C-terminal region.
The presence of several nuclear localization sequences is in
agreement with the reported nuclear localization of the protein
(8). The presence of several PEST sequences suggests that
Brd4 may be unstable (31).
Sequence comparison of the murine Brd4 cDNA (NCBI
accession number NM 0205508) with murine genomic se-
quences (GenBank accession no. AC074208, AC073765, and
AC073779) revealed that Brd4 is transcribed from 20 exons
spanning at least 110 kb (GenBank accession no. AF461395)
(Fig. 1a). As noted in reference 8, the Brd4 gene shares the
highest sequence identity with the uncharacterized human
HUNK1 cDNA (NCBI accession number NM 014299), which
encodes a protein of 722 amino acids, which is much smaller
than Brd4. Using 3 RACE performed on the E11 cDNA
library and RT-PCR procedures performed on adult tissues,
we were able to reveal the existence of an alternative 13th exon
(13S [short]) that encodes three C-terminal amino acids as well
as an alternative 3 UTR. Use of the exon 13L (long) is pre-
dicted to lead to the synthesis of a 6-kb transcript coding for a
1,400-amino acid protein. Use of the exon 13S is predicted to
lead to the synthesis of a 3.5-kb transcript coding for a 722-
amino acid protein with 96% identity with the HUNK1 protein
(Fig. 1a) (GenBank accession no. AF461396). Sequence com-
parison of the murine and human Brd4 cDNAs to human
genomic sequences (NT 011290) revealed that the human gene
contains the same number of exons as the mouse gene and
covers 43.6 kb. In both species, exon 13S is located between
exons 12 and 13L and is highly conserved (85% identity over
414 bp). However, although we were able to reveal the exis-
tence of this short transcript by RT-PCR and 3 RACE, we
were unable to detect it by Northern blotting or in situ hybrid-
ization, a result in agreement with the single-size protein de-
tected by Western blotting (8). Therefore, the biological sig-
nificance of this short transcript remains elusive. In conclusion,
both the high sequence identity and the similarities in genomic
organization strongly suggest that Brd4 is the mouse ortho-
logue of HUNK1.
Brd4 belongs to a group of structurally related proteins.
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Several proteins that are characterized by the association of
two N-terminal bromodomains with a more C-terminal ET
domain have now been identified. We compared the motif
organizational structures (Fig. 2a) and sequences (Fig. 2b) of
the different members of this family. Besides their bromodo-
mains and ET domains, all the vertebrate members of the
Fsh/Brd family as well as the Drosophila fs(1)h protein contain
identical short stretches of 11 amino acids (GVKRKADTTTP)
(Fig. 2a). This motif was not encountered in any other protein
present in the databases, and its function is presently unknown.
The Brd2/RING3 protein was originally described as a mi-
togen-activated nuclear kinase (6), although the existence of
kinase activity of Brd2 remains controversial (7, 30, 32). We
compared the sequences of the kinase motifs described for
Brd2 with the Brd4 sequence. Neither the Brd2 putative ATP
binding motif (LGPSGFGPS) nor the putative catalytic lysine
(ATK) was conserved in Brd4. Therefore, if Brd2 has a kinase
activity, it is unlikely to be conserved in Brd4. However, it
remains possible that Brd4 is able to recruit another protein
with kinase activity, since such a function has been proposed
for Brd2 (30).
One member of the Fsh/Brd family has been isolated in the
mouse counterpart of the yeast mediator of transcriptional
regulation, the role of which is to integrate the positive and
negative regulatory information originating from enhancer and
silencer elements. It then transmits this information to the
RNA polymerase II, modulating its activity in promoter-de-
pendent transcription (18). At the time, Jiang et al. could not
identify the member of the family that they had purified. When
we compared the protein sequences of the three Brd-like pep-
tides that they isolated with those of the four members of the
Fsh/Brd family, we found that they were 100% identical to
parts of the bromodomain II (peptides p66 and p96a1) and ET
domains (peptide p96a2) of Brd4 (46 amino acids out of 46)
(Fig. 2c). The other members of the mammalian Brd family did
not share 100% identity with the peptides (41-of-46 amino acid
identity for Brd2; 40 of 46 for Brd3; 40 of 46 for Brd5). These
peptides are not predicted to be encoded by any other putative
open reading frame presently identified in the human or
mouse genome. Therefore, we conclude that Brd4 is very likely
to be the protein identified by Jiang et al. as a component of
the mediator.
Brd4 is located on mouse chromosome 17 and reveals a
conservation of synteny with human chromosome 19p13.1.
BRD4/HUNK1 is located on human chromosome 19p13.1, 35.6
kb from the Notch3 gene (NT 011290). The mouse-hamster
RH panel was used to map both mouse Brd4 and Notch3 on the
mouse genome. We localized Brd4 and Notch3 on mouse chro-
mosome 17 between markers D17Mit181 and D17Mit191, a
result confirmed by the presence of both genes on the draft
FIG. 1. The gene trap strategy and Brd4 gene. (a) Structure of the Brd4 and Brd4gt transcripts. A long Brd4 mRNA (6 kb, encoding a
1,400-amino acid protein) is transcribed from 20 exons (1 to 20), and a short Brd4 mRNA (3.5 kb, encoding a 722-amino acid protein) is formed
by the use of an alternative 13th exon (13S). The fusion transcript containing the first two noncoding exons from Brd4 fused to the gene trap
sequences is transcribed from the Brd4gt allele. 1f, 1r, and 2r are the specific primers used for RT-PCR in Fig. 1b. Dotted boxes, UTR; plain boxes,
coding exons; nis, nuclear localization signal; TM, transmembrane domain. (b) RT-PCR with primers 1f (5 RACE fragment specific), 1r
(Brd4-specific coding sequence), and 2r (gene trap-specific primer). Primers 1f and 2r (1f-2r) amplified the expected 338-bp product in total RNA
from Brd4gt/Brd4 (h) but not Brd4/Brd4(w) individuals. Primers 1f and 1r (1f-1r) amplified the expected 256-bp fragment in total RNA from
both wild types and heterozygotes. (c and d) Brd4/Brd4 (c) and Brd4gt/Brd4gt (d) blastocyst explants cultured for 2 days and hybridized with a
probe covering exons 1 to 9 and part of exon 10. No transcript could be detected in the homozygote.
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genome sequence (GenBank accession no. AC074208). This
localization reveals a short conservation of synteny between
Brd4/Notch3 on chromosome 17 on the mouse genome and
HUNK1/NOTCH3 on chromosome 19p13.1 on the human ge-
nome. This conservation of synteny gives further evidence for
the orthology between Brd4 and HUNK1. Interestingly, the
three other members of the Fsh/Brd family also map close to
members of the Notch family, at least in humans. Brd2 maps
next to Notch4 on human chromosome 6, Brd3 next to Notch1
on human chromosome 9, and Brd5 next to Notch2 on human
chromosome 1 (reviewed in reference 20).
Brd4gt is a null allele of Brd4. The gene trap vector inte-
grated within the second intron of Brd4. A fusion mRNA
containing the noncoding exons 1 and 2 from Brd4 spliced to
the gene trap sequences is predicted to be transcribed from the
trapped locus (Fig. 1a and b). Therefore, the transcript en-
coded by the gene trap allele (designated Brd4gt) should not
contain any Brd4 coding sequences. In order to confirm that we
had indeed generated a null allele of Brd4, we cultured blas-
tocysts from Brd4gt/Brd4  Brd4gt/Brd4 matings. Using in
situ hybridization with a probe spanning Brd4 exons 1 to 9 and
part of exon 10, we showed that blastocyst explants homozy-
gous for Brd4gt are clearly recognizable by the absence of Brd4
transcript, even after extended periods of staining (compare
Fig. 1c and d). In order to ensure a homogeneous genetic
background and to eliminate any independent mutation that
may have occurred in the ES cell clone, we backcrossed the
heterozygotes onto a C57BL6/J background for five to eight
generations. In parallel, fluorescent in situ hybridization anal-
ysis of the G-banded metaphase spread of ST132 ES cells
revealed that only a single gene trap vector insertion was evi-
dent and that it coincided grossly with the position of Brd4
(data not shown). We conclude from these results that the
phenotype in Brd4gt mice (see below) is attributable to a null
allele of Brd4.
Expression pattern of Brd4. In Brd4gt/Brd4 embryos, we
detected a faint expression of the lacZ reporter gene from the
blastocyst stage onwards. We also showed that the gene is
strongly expressed in blastocyst explants (Fig. 1c and Fig. 6d
and f). In E6 embryos, the expression of the reporter gene was
ubiquitous but the intensity of the signal appeared to be stron-
ger in the embryonic than in the extraembryonic part of the
FIG. 2. Structure of the Brd4 gene and conservation of the Brd family. (a) Domain organizations of the different members of the Brd/fs(1)h
family. A convenient nomenclature for the vertebrate members of this family based on the root fsrg (female sterile homeotic related) was proposed
by Rhee et al. (32). However, here we use the nomenclature retained by the Mouse Gene Informatics Nomenclature Committee, who proposed
the root Brd to designate the members of this bromodomain-containing family. Bromodomains are shown in blue, ET domains are shown in red,
and the conserved 10-amino acid motif is shown in orange. Note that the hffsh sequence is only partial and terminates in the ET domain. (b)
Similarity tree of the members of the Brd family (vertebrate members of the family are underlined). Note that Brd2/RING3 and Brd3/ORFX group
together, in agreement with the important conservation of synteny observed between human chromosomes 6 and 9 (see reference 21 for review).
Brd5/BRDT, the only member of the Brd family that exhibits a nonubiquitous pattern of expression (19), is found outside the mammalian group,
suggesting a possible divergent function. Bdf1 and Bdf2 group together, suggesting a duplication after the separation between yeast and metazoans.
Alignments of bromodomains also confirmed this result (data not shown). (c) Sequence comparison of the Ring3-like peptides (p66, p96a1, and
p96a2) (isolated in the study cited in reference 18) with those of the four mammalian members of the Brd family. Arrows point at the sequences
of the peptides and Brd4.
VOL. 22, 2002 FUNCTIONAL ANALYSIS OF THE MOUSE Brd4 GENE 3797
conceptus (see Fig. 6a). The highest level of expression was
observed in E10 and E11 embryos (data not shown). At later
stages of development and after birth, Brd4 remains expressed
in all tissues tested, although the levels of expression differ
(reference 8 and D. Houzelstein, unpublished data).
Postnatal death of Brd4gt/Brd4 individuals. Shortly after
birth, the expected 1:1 ratio of heterozygous to wild-type indi-
viduals was observed from Brd4gt/Brd4  Brd4/Brd4 mat-
ings (Fig. 3a). However, 12 to 17 days after birth (P12 to P17),
about 50% of the heterozygotes were missing, whereas after
FIG. 3. In vivo phenotype of the heterozygotes. (a) Postnatal lethality: comparison between the average numbers of Brd4/Brd4 (plain line)
and Brd4gt/Brd4 (dotted line) individuals per litter from matings of Brd4gt/Brd4 males with Brd4/Brd4 females, from birth to adulthood. The
number indicated above each point represents the average number of individuals per litter. Note that the expected ratio of heterozygous to
wild-type individuals was observed at birth. n, number of individuals counted. (b) Growth defect before birth: average weights of Brd4/Brd4 and
Brd4gt/Brd4 individuals from E10 to E19. At least three littermate individuals from each genotype were counted at every point. Heterozygote
versus wild-type weight percentages are indicated. Note that the difference in weight between heterozygous and wild-type individuals is most
pronounced between E10 and E11. (c) Growth defect after birth. Six Brd4gt/Brd4 and five Brd4/Brd4 Brd4gt/Brd4 males were weighed over
a period of 320 days. Wild-type individuals (plain line) were significantly heavier than their heterozygous (dotted line) littermates. Weights of both
males and females from several litters gave results quantitatively and qualitatively similar. The average weight is indicated over each point, and
heterozygote versus wild-type weight percentages are indicated in the squares. (d) Growth defect of individual organs. Individual organs from
Brd4/Brd4 and Brd4gt/Brd4 10-month-old females were weighed separately. Every organ was affected by the mutation. (e) Reduced numbers
of mitotic cells in the Brd4gt/Brd4 individuals. An anti-phospho-histone H3 antibody was used to reveal mitotic cells from E15 liver and lung
sections. An enlargement of part of such a section is shown. The average numbers of mitotic cells per section are indicated. There were significantly
fewer mitotic cells in sections from heterozygous embryos than in those from wild-type embryos, although the cell density was unaffected.
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P17 the proportions of heterozygous individuals remained rel-
atively constant, indicating a critical period for survival during
the first 2 weeks of postnatal life. No significant numbers of
deaths occurred in wild-type C57BL6/J littermates over this
period.
Prenatal and postnatal growth defects of the Brd4gt/Brd4
individuals. While the cause of heterozygous death remained
unclear, these individuals appeared consistently smaller than
wild-type littermates. Therefore, heterozygous and wild-type
individuals were systematically weighed before and after birth.
At E10, the heterozygotes weighed, on average, 25% less than
their wild-type littermates. This growth defect was maintained
throughout the prenatal period until birth (Fig. 3b). After
birth, the defect was less pronounced, since heterozygotes were
only 10% lighter than the wild types (Fig. 3c). The weights of
several organs from heterozygous adults were reduced in sim-
ilar proportion compared to those of wild types (Fig. 3d). Since
the growth defect was maintained throughout life, it is unlikely
to result from an abnormal growth hormone pathway, which
acts only after birth. A defect in nutrient supply from the
mother also seems unlikely, since the growth defect was main-
tained after birth and weaning (Fig. 3a). To address the cause
of the growth defect, we performed immunolabeling experi-
ments on lung and liver sections by using an antibody directed
against phospho-histone H3, a specific marker of mitotic cells
(14) (Fig. 3e). We found a significantly reduced number of
mitotic cells in heterozygotes compared to that in wild-type
tissue (Fig. 3c). Taken together, these results indicate that the
general growth restriction observed in heterozygous tissues is
likely to be due to a reduction in the proliferation rate.
Anatomical defects of the Brd4gt/Brd4 individuals. A few
weeks after birth, the heterozygotes were easily recognizable
because of the abnormal shape of their heads. Skeleton prep-
arations from 8-week-old heterozygous and wild-type animals
revealed that this recognizable facies was due to a shorter
incisive bone as well as a shorter and bent nasal bone (Fig. 4a
and b). The mandible was also reduced in length. No discern-
ible differences between the axial and appendicular skeletons
of the wild types and heterozygotes could be found (data not
shown).
Various morphological abnormalities were seen in the skin,
liver, testis (epididymal duct and vas deferens), and brain of
heterozygotes. In the skin, the epidermis appeared abnormally
thick, although the layers were clearly recognizable. The sub-
cutaneous adipose tissue was considerably reduced and con-
tained degenerating cells surrounded by infiltrating macro-
phages. The dermis also contained an increased number of
neutrophils and mature fibrocytes (Fig. 4c and d). In the het-
erozygous liver, many hepatocytes contained one large aber-
rant nucleus or even two nuclei. Degenerated and necrotic
hepatocytes surrounded by phagocytes (Küpffer cells and neu-
trophils) were also detected (Fig. 4e and f). In the testis,
several abnormal seminiferous tubules lacking spermatogenic
cells that might indicate impaired spermatogenesis were also
noted. In the epididymis and vas deferens, many cells of the
epithelium lining the lumen of ducts had abnormal polyploid
nuclei and were altered in size and shape. Some of the epithe-
lial cells also showed features of degeneration. In the brain, a
few necrotic neurons were observed but classical histological
procedures could not reveal any defect in myelination (data
not shown).
In a sample population of 34 heterozygotes between 6 weeks
and 6 months of age, four individuals had one or both eyes
reduced in size and seven had a cataract. No eye defects were
evident in a control group of 48 wild-type animals (data not
shown).
Heterozygous mouse embryonic fibroblasts (MEFs) have a
reduced proliferation rate and increased sensitivity to MMS.
To investigate further the cellular impact of the Brd4 heterozy-
gous condition, we isolated fibroblasts from E13 embryos. The
doubling time of heterozygous MEFs was significantly longer
(4 days) than that of wild-type control MEFs (2 days) (Fig. 5a).
We conclude that the growth restriction observed in heterozy-
gous embryos was maintained in cell culture. Therefore, MEFs
constitute an in vitro system suitable for the further analysis of
the Brd4 growth phenotype. We showed that medium condi-
tioned with wild-type MEFs could not rescue the phenotype of
heterozygous MEFs, suggesting that the growth restriction
phenotype is cell autonomous (data not shown).
FIG. 4. Anatomical and histological defects in the heterozygotes.
(a, a, b, and b) Skeletal preparations of two-month-old Brd4/Brd4
(a) and Brd4gt/Brd4 (b) male skulls, respectively; bone is stained in
red and cartilage in blue. Note the shorter and bent nasal bone (ar-
row), the shorter incisor bone (arrowhead), and the shorter mandible
of the heterozygote. f, frontal bone; i, incisive bone; ip, interparietal
bone; lf, lacrimal foramen; m, mandible; mp, mastoid process; n, nasal
bone; o, occipital bone; os, orbital surface of the frontal bone; p,
parietal bone; t, temporal bone; tb, tympanic bulla; z, zygomatic bone.
(c and d) Sections through the skin of two Brd4/Brd4 (c) and Brd4gt/
Brd4 (d) 1-month-old individuals. In the heterozygote, the epidermis
(e) was thickened and the amount of subcutaneous adipose tissue (s)
was reduced and contained degenerating adipose cells surrounded by
phagocytic cells (black arrow). d, dermis; m, muscle. (e and f) Sections
through the liver of two Brd4/Brd4 (e) and Brd4gt/Brd4 (f)
2-month-old individuals. The black arrow in Fig. 4f points to degen-
erating hepatocytes, and the white arrowheads point at surrounding
phagocytes in the heterozygote.
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Some aspects of the heterozygous growth restriction pheno-
type are reminiscent of those observed in various mutants
affected in different DNA damage repair pathways (see refer-
ence 11 for review). Thus, we tested the survival of heterozy-
gous cells after exposure to ionizing radiation (IR). IR is
known to induce lesions that are the substrate for the nonho-
mologous end joining repair pathway and the transcription-
coupled repair pathway (21). For the doses tested, no differ-
ence could be seen between heterozygous and wild-type MEFs
(Fig. 5b). When heterozygous thymocytes were tested, the rel-
ative insensitivity to IR was also observed and the absence of
nonhomologous end joining deficiency in these cells was cor-
roborated by the normal generation of T-cell receptor variable
region diversity (data not shown).
We then measured the survival of heterozygous cells follow-
ing exposure to MMS. MMS induces lesions, such as N-meth-
ylpurines (29), which are substrates for the base excision repair
pathway (see reference 22 for a recent review). We detected up
to a twofold increase in sensitivity to MMS of heterozygous
cells compared to that detected in wild-type cells (Fig. 5c).
Finally, the survival of heterozygous cells following exposure
to UV radiation was assayed. Lesions induced by UV radia-
tion, such as pyrimidine dimers, are substrates for the nucleo-
tide excision repair pathway. No clear difference could be de-
tected between heterozygous and wild-type cells in these
conditions (Fig. 5d).
Characterization of the homozygous phenotype in vivo and
in vitro. To investigate the phenotype of individuals nullizy-
gous for Brd4, heterozygous individuals were mated. No Brd4gt/
Brd4gt homozygous progeny could be identified by in situ hy-
bridization performed on midgestation litters (0 of 22). Out of
43 decidua recovered between E7 and E9, wild-type (10 of 43)
and heterozygous embryos (24 of 43) were observed in the
expected proportions. The remaining 25% of decidua (9 of 43),
likely to correspond to the missing homozygotes, were empty,
suggesting postimplantation lethality. When heterozygous fe-
males were mated with wild-type males, no empty site was
recovered (0 of 23), indicating that the lethality observed in
heterozygous matings was not due to a maternal defect. A
number of E6 decidua were processed for histological exami-
nation. In 7 out of 37 cases, the embryonic region was absent
(Fig. 6c; compare with a wild type in Fig. 6b). The embryonic
region was the part of the conceptus where expression of the
reporter gene was predominantly detected (Fig. 6a), whereas
the extraembryonic region, which normally expresses Brd4 at
lower levels, was less affected in the homozygous mutants (Fig.
6a to c).
To test whether homozygous embryos survive to the blasto-
cyst stage, embryos were isolated at E3, at which point they
showed no overt developmental delay and were morphologi-
cally indistinguishable from wild-type blastocysts (data not
shown). The growth potential of wild-type and mutant blasto-
cysts was monitored in vitro over a period of 2 to 5 days.
During the first 2 days, both wild-type and homozygous blas-
FIG. 5. Effect of DNA damaging agents on survival of MEFs. (a) 1.00  105 Brd4/Brd4 (plain line) or Brd4gt/Brd4 (dotted line) MEFs were
harvested on individual plates at day 0 and counted at 4-day intervals. (b to d) MEFs were plated as for Fig. 5a. After they adhered to the plate,
they were submitted to increasing doses of IR (b), MMS (c), or UV (d), cultured for 8 days, and counted.
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tocysts hatched out of the zona pellucida and attached to the
slide. During this period, explants grown from homozygous
embryos, as assayed by the absence of Brd4 transcript, ap-
peared morphologically normal, albeit smaller than wild types
(compare Fig. 1c and d). After 5 days in culture, two cell
populations were clearly recognizable morphologically in ex-
plants from wild-type blastocysts: flat, spread-out, giant tro-
phoblast cells (Fig. 6d) and the smaller inner-cell-mass cells
(Fig. 6d and 6e). In explants grown from homozygous embryos,
trophoblast giant cells were clearly recognizable and did not
appear necrotic, whereas cells from the inner cell mass com-
pletely degenerated (Fig. 6f). Therefore, at least one copy of
Brd4 is required for the maintenance of the inner cell mass.
DISCUSSION
We have examined the consequences of a gene trap inser-
tion resulting in a null mutation in the Brd4 gene. We showed
that Brd4 is expressed ubiquitously from the blastocyst stage
and that nullizygous mutant embryos implant in the uterine
wall but arrest in their development shortly thereafter, indicat-
ing that Brd4 exerts cellular functions essential for early
postimplantation development. We have also found that indi-
viduals with only one functional allele of the Brd4 gene are
growth restricted both before and after birth. Growth restric-
tion is also observed in primary cell cultures and is therefore
not dependent on diffusible growth factors, either in the me-
dium or from wild-type cells. Thus, the defect appears to be
cell autonomous, consistent with a predicted nuclear location
for Brd4. We showed that, in vivo, deletion of only one Brd4
allele results in a reduction of the number of mitotic cells in at
least two embryonic tissues. This result is consistent with the in
vitro observation that microinjection of anti-Brd4 antibodies
into HeLa cell nuclei completely inhibits entry into mitosis (8).
The reduced mitotic activity is likely to underlie the growth
restriction during the whole life of Brd4gt heterozygotes. This
growth restriction is most pronounced at E10 and E11 (i.e., the
earliest stage tested), when cell division is relatively rapid and
the reduced proliferative ability of the Brd4gt cells is likely to be
most detrimental.
The complex set of anatomical defects exhibited by the
Brd4gt/Brd4 mutants is reminiscent of some of the defects
observed in two related human syndromes, Cockayne syn-
drome (CS) and trichothiodystrophy (TTD). They include par-
tial lethality, impaired growth, peculiar facies, lack of subcu-
taneous fat, and cataracts (see references 2 and 3 for recent
reviews). Patients suffering from these syndromes are affected
in DNA repair pathways resulting, in particular, in severe sen-
sitivity to UV radiation. However, we demonstrate that Brd4-
deficient cells do not display sensitivity to ionizing and UV
radiation, excluding a major role for Brd4 in these pathways.
Heterozygous cells appeared significantly more sensitive to
MMS than wild-type cells, suggesting a defect in DNA damage
repair. However, this could be a primary or secondary conse-
quence of the mutation. Interestingly, a similar phenotype
(slow growth, sensitivity to MMS, and relative insensitivity to
IR) was also described for the yeast Bdf1 mutant.
However, since TTD and CS are now known to be the
consequence of defects in both DNA repair and transcription
(see references 2 and 3 for recent reviews), impaired transcrip-
tion in the Brd4gt mutants remains a possibility to explain the
phenotypic similarities between the Brd4gt mutants and
TTD-CS patients. Consistent with this possibility is our dem-
onstration that Brd4 is very likely to be a component of the
mediator of transcriptional regulation isolated in the study
cited in reference 18. However, the transcriptional coactivator
function of the murine mediator has yet to be demonstrated
(18) and many other mammalian mediator-related complexes
have been characterized extensively and do not appear to con-
tain any Brd family member as a constitutive unit (see refer-
ences 12 and 26 for reviews). Therefore, the question of
whether Brd4 or other members of the Fsh/Brd family act as a
constitutive unit of the mediator awaits detailed biochemical
analyses. Nevertheless, it is noteworthy that the defects in Brd4
nullizygous embryos are very similar to those found when Srb7,
which encodes the only other protein isolated as part of the
mediator whose function has been inactivated in mice, is de-
leted. Srb7 nullizygous embryos also die shortly after implan-
tation, and the inner cell mass of blastocysts grown in culture
degenerates (38).
Summary. Our results suggest that a fundamental cellular
process is impaired in Brd4gt cells and that the complex patho-
logical features observed in Brd4gt/Brd4 individuals might be
explained by a global deficiency in a basic mechanism, resulting
in reduced proliferative ability. Indeed, the most remarkable
defect of Brd4gt/Brd4 mice is their pre- and postnatal growth
defect. Given that this phenotype is associated with haploin-
FIG. 6. The homozygote phenotype. (a to c) E6 embryos. Black
arrows demarcate the embryonic part of the conceptus, whereas the
black arrowhead points at the extraembryonic part. Whole-mount
-galactosidase staining of a Brd4gt/Brd4 embryo (a) and hematoxy-
lin-eosin staining of sections of Brd4/Brd4 (b) and Brd4gt/Brd4gt (c)
embryos are shown. Note that the embryonic part which normally
expresses the gene strongly is missing in the homozygote. (d to f)
Blastocyst explants stained with -galactosidase after 5 days in culture.
The arrows point at the giant trophoblastic cells, and the arrowhead
points at the inner cell mass. In Fig. 6e, the limit of trophoblast giant
cell spread is indicated by a dotted line. In Fig. 6f, the inner cell mass
of the homozygote has degenerated and is missing.
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sufficiency in the mouse, heterozygous mutations in the Brd
human homologues could also be associated with pre- and
postnatal growth defects. Therefore, Brds may be candidate
genes for some human disorders characterized by a short stat-
ure. Thus, the Brd4gt mouse mutant will be of great value, not
only in elucidating Brd protein function during pre- and post-
natal life but also as a model for human pathology.
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